Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal

Abstract

Nitric oxide (NO), peroxynitrite, and 4-hydroxynonenal (HNE) may be involved in the pathological demise of cells via apoptosis. Apoptosis induced by these agents is inhibited by Bcl-2, suggesting the involvement of mitochondria in the death pathway. In vitro, NO, peroxynitrite and HNE can cause direct permeabilization of mitochondrial membranes, and this effect is inhibited by cyclosporin A, indicating involvement of the permeability transition pore complex (PTPC) in the permeabilization event. NO, peroxynitrite and HNE also permeabilize proteoliposomes containing the adenine nucleotide translocator (ANT), one of the key components of the PTPC, yet have no or little effects on protein-free control liposomes. ANT-dependent, NO-, peroxynitrite- or HNE-induced permeabilization is at least partially inhibited by recombinant Bcl-2 protein, as well as the antioxidants trolox and butylated hydroxytoluene. In vitro, none of the tested agents (NO, peroxynitrite, HNE, and tert-butylhydroperoxide) causes preferential carbonylation HNE adduction, or nitrotyrosylation of ANT. However, all these agents induced ANT to undergo thiol oxidation/derivatization. Peroxynitrite and HNE also caused significant lipid peroxidation, which was antagonized by butylated hydroxytoluene but not by recombinant Bcl-2. Transfection-enforced expression of vMIA, a viral apoptosis inhibitor specifically targeted to ANT, largely reduces the mitochondrial and nuclear signs of apoptosis induced by NO, peroxynitrite and HNE in intact cells. Taken together these data suggest that NO, peroxynitrite, and HNE may directly act on ANT to induce mitochondrial membrane permeabilization and apoptosis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

Abbreviations

AIF:

apoptosis-inducing factor

ANT:

adenine nucleotide translocator

COX:

cytochrome c oxidase

CsA:

cyclosporin A

Cyt c:

cytochrome c

DiOC6(3):

3,3′dihexyloxacarbocyanine iodide

ΔΨm:

mitochondral transmembrane poteintal

BHT:

butylated hydroxytoluene

HE:

hydroethidine

HNE:

4-hydroxynonenal

4-MU:

4-methylumbelliferone

4-MUP:

4-methylumbelliferylphosphate

ROS:

reactive oxygen species

SIN-1:

3-morpholinosydnonimine

SNAP:

S-nitroso-N-acetylpenicillamine

PTPC:

permeability transition pore

SOD:

superoxide dismutase

t-BHP:

tert-butyhlhydroperoxide

VDAC:

voltage-dependent anion channel

vMIA:

viral mitochondria-localized inhibitor of apoptosis

References

  • Aillet F, Masutani H, Elbim C, Raoul H, Chene L, Nugeyre MT, Paya C, Barre-Sinoussi F, Gougerot-Pocidalo MA, Israel N . 1998 J. Virol. 72: 9698–9705

  • Allione A, Bernabei P, Bosticardo M, Ariotti S, Forni G, Novelli F . 1999 J. Immunol. 163: 4182–4191

  • Bauer MKA, Schubert A, Rocks O, Grimm S . 1999 J. Cell Biol. 147: 1493–1501

  • Bernardi P, Petronilli V, di Lisa F, Forte M . 2001 Trends Biochem. Sci. 26: 112–117

  • Bou Hamdan M, Xue Y, Baudat Y, Hu B, Sire J, Pomerantz RJ, Duan LX . 1998 J. Biol. Chem. 273: 8009–8016

  • Brenner C, Cadiou H, Vieira HLA, Zamzami N, Marzo I, Xie Z, Leber B, Andrews D, Duclohier H, Reed JC, Kroemer G . 2000 Oncogene 19: 329–336

  • Brenner C, Kroemer G . 2000 Science 289: 1150–1151

  • Brookes PS, Salinas EP, Darley-Usmar K, Eiserich JP, Freeman BA, Darmey-Usmar VM, Anderson PG . 2000 J. Biol. Chem. 275: 20474–20479

  • Brune B, von Knethen A, Sandau KB . 1999 Cell Death Differ. 6: 969–975

  • Brustovetsky N, Klingenberg M . 1996 Biochemistry 35: 8483–8488

  • Buege JA, Aust SD . 1978 Meth. Enzymol. 52: 302–310

  • Clementi E, Brown GC, Foxwell N, Moncada S . 1999 Proc. Natl. Acad. Sci. 96: 1559–1562

  • Costantini P, Belzacq A-S, Vieira HLA, Larochette N, de Pablo M, Zamzami N, Susin SA, Brenner C, Kroemer G . 2000 Oncogene 19: 307–314

  • Costantini P, Chernyak BV, Petronilli V, Bernardi P . 1996 J. Biol. Chem. 271: 6746–6751

  • Crompton M . 1999 Biochem. J. 341: 233–249

  • Crompton M, Virji S, Ward JM . 1998 Eur. J. Biochem. 258: 729–735

  • Daugas E, Susin SA, Zamzami N, Ferri K, Irinopoulos T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G . 2000 FASEB J. 14: 729–739

  • Dorner A, Olesch M, Giessen S, Pauschinger M, Schulheiss HP . 1999 Biochim. Biophys. Acta 1417: 16–24

  • Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson GJ, Tarpey MM, Barbeito L, Beckman JS . 1999 Science 286: 2498–2500

  • Evan HI, Lewis GK, Ramsay G, Bishop JM . 1985 Mol. Cell. Biol. 5: 3610–3616

  • Ferri KF, Jacotot E, Blanco J, Esté JA, Zamzami A, Susin SA, Brothers G, Reed JC, Penninger JM, Kroemer G . 2000 J. Exp. Med. 192: 1081–1092

  • Ghafourifar P, Schenk U, Klein SD, Richter C . 1999 J. Biol. Chem. 274: 31185–31188

  • Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ, Morrison RS . 2000 J. Cell Biol. 150: 335–347

  • Glockzin S, von Knethen A, Scheffner M, Brune B . 1999 J. Biol. Chem. 274: 19581–19586

  • Goldmacher VS, Bartle LM, Skletskaya S, Dionne CA, Kedersha NL, Vater CA, Han JW, Lutz RJ, Watanabe S, McFarland EDC, Kieff ED, Mocarski ES, Chittenden T . 1999 Proc. Natl. Acad. Sci. USA 96: 12536–12541

  • Green DR, Reed JC . 1998 Science 281: 1309–1312

  • Groves JT . 1999 Curr. Opin. Chem. Biol. 3: 226–235

  • Hashimoto M, Majima E, Goto S, Shinohara Y, Terada H . 1999 Biochemistry 38: 1050–1056

  • Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ . 1993 Cell 75: 241–251

  • Hortelano S, Alvarez AM, Bosca L . 1999 FASEB J. 13: 2311–2317

  • Hortelano S, Dallaporta B, Zamzami N, Hirsch T, Susin SA, Marzo I, Bosca L, Kroemer G . 1997 FEBS Lett. 410: 373–377

  • Huwiler A, Pfeilschifter J, van den Bosch H . 1999 J. Biol. Chem. 274: 7190–7195

  • Jacotot E, Ferri KF, El Hamel C, Brenner C, Druillenec S, Hoebeke J, Rustin P, Métivier D, Lenoir C, Geuskens M, Vieira HLA, Loeffler M, Belzacq A-S, Briand JP, Zamzami N, Edelman L, Xie ZH, Reed JC, Roques BP, Kroemer G . 2001 J. Exp. Med. 193: 509–520

  • Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HLA, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Brian JP, Irinopoulos T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP, Kroemer G . 2000 J. Exp. Med. 191: 33–45

  • Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC . 1998 Proc. Natl. Acad. Sci. USA 95: 4997–5002

  • Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD . 1997 Science 275: 1132–1136

  • Koppenol WH, Moreno JJ, Ryor WA, Ischiropoulos H, Beckman JS . 1990 Chem. Res. Toxicol. 5: 834–842

  • Kristal BS, Park BK, Yu BP . 1995 J. Biol. Chem. 271: 6033–6038

  • Kroemer G, Dallaporta B, Resche-Rigon M . 1998 Annu. Rev. Physiol. 60: 619–642

  • Kroemer G, Reed JC . 2000 Nat. Med. 6: 513–519

  • Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP . 1997 J. Neurosci. 17: 5089–5100

  • Liu XS, Kim CN, Yang J, Jemmerson R, Wang X . 1996 Cell 86: 147–157

  • Lopez-Figueroa MO, Caamano C, Morano MI, Ronn LC, Akil H, Watson SJ . 2000 Biochem. Biophys. Res. Comm. 272: 129–133

  • Marzo I, Brenner C, Zamzami N, Jürgensmeier J, Susin SA, Vieira HLA, Prévost M-C, Xie Z, Matsuyama S, Reed JC, Kroemer G . 1998a Science 281: 2027–2031

  • Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Rémy R, Xie ZH, Reed JC, Kroemer G . 1998b J. Exp. Med. 187: 1261–1271

  • Massari P, Ho Y, Wetzler LM . 2000 Proc. Natl. Acad. Sci. USA 97: 9070–9075

  • Mattson MP . 1998 Trends Neurosci. 21: 53–57

  • Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi Agro A . 1997 Nature 388: 432–433

  • Mossalaly MD, Becherel PA, Debre P . 1999 Mol. Med. 5: 812–819

  • Murphy MP . 1999 Biochem. Biophys. Acta 1411: 401–414

  • Nicotera P, Bernassola F, Melino G . 1999 Cell Death Differ. 6: 931–933

  • Petit PX, Goubern M, Diolez P, Susin SA, Zamzami N, Kroemer G . 1998 FEBS Lett. 426: 111–116

  • Rahmani Z, Huh KW, Lasher R, Siddiqui A . 2000 J. Virol. 74: 2840–2846

  • Shimizu S, Ide T, Yanagida T, Tsujimoti Y . 2000 J. Biol. Chem. 275: 12321–12325

  • Shimizu S, Narita M, Tsujimoto Y . 1999 Nature 399: 483–487

  • Susin SA, Larochette N, Geuskens M, Kroemer G . 2000 Meth. Enzymol. 322: 205–208

  • Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G . 1999 Nature 397: 441–446

  • Szweda LI, Uchida K, Tsai L, Stadtman ER . 1993 J. Biol. Chem. 268: 3342–3347

  • Uchida K, Stadtman ER . 1992 Proc. Natl. Acad. Sci. USA 89: 4544–4548

  • Ushmorov A, Ratter F, Lehmann V, Droge W, Schirrmacher V, Umansky V . 1999 Blood 93: 2342–2352

  • Vieira HL, Haouzi D, El Hamel C, Belzacq AS, Brenner C, Kroemer G . 2000 Cell Death Differ. 7: 1146–1154

  • Woodfield K, Ruck A, Brdiczka D, Halestrap AP . 1998 Biochem. J. 336: 287–290

  • Yan LJ, Sohal RS . 1998 Proc. Natl. Acad. Sci. USA 95: 12896–12901

  • Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G . 1995 J. Exp. Med. 182: 367–377

  • Zamzami N, Susin SA, Marchetti P, Hirsch T, Gómez-Monterrey I, Castedo M, Kroemer G . 1996 J. Exp. Med. 183: 1533–1544

Download references

Acknowledgements

We thank Dr Nicole Israel (Pasteur Institute, Paris) for Bcl-2 transfected Jurkat cells, Z Xie and JC Reed (Burnham Institute, La Jolla, CA, USA) for recombinant Bcl-2, Dr MP Mattson (NIH, Bethesda, USA) for anti-HNE antibody, and D Métivier (CNRS, Villejuif, France) for cytofluorometric analyses. This work has been supported by a special grant from the Ligue Nationale contre le Cancer, Comité Val de Marne de la Ligue contre le Cancer, as well as grants from ANRS (to G Kroemer), FRM (to G Kroemer and C Brenner), and the European Commission Grant No. QL61-1999-00739 (to G Kroemer and G Melino). HLA Vieira receives a fellowship from the Fundação para a Ciência e a Tecnologia PRAXIS XXI, Portugal; A-S Belzacq from ARC, E Jacotot from ANRS.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guido Kroemer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vieira, H., Belzacq, AS., Haouzi, D. et al. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305–4316 (2001). https://doi.org/10.1038/sj.onc.1204575

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204575

Keywords

This article is cited by

Search

Quick links